rs10838738 — MTCH2

Intronic GWAS obesity variant in MTCH2 — affects mitochondrial energy balance, adipogenesis, and fatty acid oxidation through CPT1 regulation

See your personal result for MTCH2

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

MTCH2 — The Mitochondrial Gatekeeper of Fat and Energy

MTCH2 (Mitochondrial Carrier Homolog 2) encodes a protein embedded in the outer mitochondrial membrane that regulates how your cells burn fat versus store it. The rs10838738 variant is an intronic SNP that functions as a cis-eQTL11 cis-eQTL
a genetic variant that affects the expression level of a nearby gene, increasing MTCH2 mRNA expression in adipose tissue. Higher MTCH2 levels tip the balance toward fat storage over fat oxidation.

The Mechanism

MTCH2 sits on the outer mitochondrial membrane where it directly regulates CPT122 CPT1
carnitine palmitoyltransferase 1, the rate-limiting enzyme for fatty acid entry into mitochondria for oxidation. When MTCH2 is abundant, it increases CPT1 sensitivity to malonyl-CoA33 malonyl-CoA
a metabolic intermediate that inhibits fat oxidation when energy is plentiful, effectively putting a brake on fatty acid oxidation. Conversely, when MTCH2 is reduced, CPT1 becomes less sensitive to malonyl-CoA inhibition, allowing increased fat burning.

The G allele at rs10838738 is in near-complete linkage disequilibrium (R2 = 0.997) with rs1064608, which encodes a p.Pro290Ala44 p.Pro290Ala
a proline-to-alanine substitution affecting protein function missense change in MTCH2. The G allele is associated with higher MTCH2 expression, leading to:

  • Enhanced CPT1 malonyl-CoA sensitivity (reduced fat oxidation)
  • Increased adipogenesis and lipid accumulation
  • Reduced mitochondrial oxidative phosphorylation efficiency
  • Lower overall energy expenditure

Mice lacking MTCH2 in muscle show increased whole-body energy utilization and protection from diet-induced obesity55 increased whole-body energy utilization and protection from diet-induced obesity
Buzaglo-Azriel et al. Loss of Muscle MTCH2 Increases Whole-Body Energy Utilization and Protects from Diet-Induced Obesity. Cell Reports, 2016, demonstrating that MTCH2 reduction is metabolically favorable for weight management.

The Evidence

The GIANT consortium66 GIANT consortium
Willer et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nature Genetics, 2009 meta-analysis of over 32,000 individuals identified MTCH2 as one of six genome-wide significant BMI loci (P = 1.9 x 10-11). The per-allele BMI increase is approximately 0.07 kg/m2.

A landmark study on opposing effects77 landmark study on opposing effects
Fischer et al. Opposing effects of genetic variation in MTCH2 for obesity versus heart failure. Human Molecular Genetics, 2023 showed that while higher MTCH2 expression increases obesity risk, reduced MTCH2 expression may be disadvantageous during heart failure, where impaired glucose oxidation and increased lactate accumulation become problematic.

Recent work in adipogenesis88 adipogenesis
Stein et al. MTCH2 controls energy demand and expenditure to fuel anabolism during adipogenesis. EMBO Journal, 2025 demonstrated that MTCH2 is essential for the energy shift from catabolism to anabolism during fat cell differentiation, controlling both energy demand and expenditure during this process.

Practical Actions

Because MTCH2 directly affects mitochondrial fat oxidation through CPT1 regulation, interventions that support mitochondrial function and fatty acid metabolism are particularly relevant for G allele carriers. Supporting the mitochondrial electron transport chain and facilitating fatty acid entry into mitochondria can help compensate for the variant's effect.

Interactions

MTCH2 rs10838738 contributes to polygenic obesity risk alongside FTO rs9939609, MC4R rs17782313, KCTD15 rs29941, and ETV5 rs7647305. The MTCH2 mechanism is unique among these — it directly affects mitochondrial fat oxidation rather than appetite regulation (MC4R, ETV5) or adipogenesis signaling (KCTD15). This makes it mechanistically complementary: an individual carrying risk alleles at both MTCH2 (reduced fat oxidation) and KCTD15 (enhanced adipogenesis) would face a compound effect on fat accumulation through two independent pathways.

Nutrient Interactions

coenzyme Q10 increased_need
L-carnitine increased_need

Genotype Interpretations

What each possible genotype means for this variant.

AA Efficient Fat Oxidation Normal

No increased obesity risk from this locus — standard mitochondrial fat burning

You carry no copies of the G risk allele at the MTCH2 locus. About 43% of people of European descent share this genotype. Your MTCH2 expression levels and CPT1-mediated fatty acid oxidation are unaffected by this variant, meaning your mitochondrial fat-burning capacity operates at the population baseline.

AG Mildly Reduced Fat Oxidation Intermediate

One risk allele — slightly increased MTCH2 expression and reduced fat oxidation

You carry one copy of the G allele at the MTCH2 locus. About 45% of Europeans share this genotype. Your adipose tissue MTCH2 expression is modestly increased, which slightly enhances CPT1 sensitivity to malonyl-CoA inhibition — meaning your mitochondria are somewhat less efficient at burning fatty acids. The per-allele BMI effect is approximately 0.07 kg/m2.

GG Reduced Fat Oxidation High Risk

Two risk alleles — significantly elevated MTCH2 expression and impaired mitochondrial fat burning

You carry two copies of the G allele at the MTCH2 locus. About 12% of Europeans share this genotype. Your adipose tissue MTCH2 expression is significantly elevated, which increases CPT1 sensitivity to malonyl-CoA and substantially reduces mitochondrial fatty acid oxidation. The combined BMI effect is approximately 0.14 kg/m2. Your cells preferentially store fat rather than burn it, and adipogenesis is enhanced during periods of energy surplus.